Emily Pimblett's Insider Trades & SAST Disclosures
Emily Pimblett's most recent trade in Climb Bio Inc. was a trade of 5,000 Common Stock done . Disclosure was reported to the exchange on March 18, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Emily Pimblett.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Climb Bio Inc. | Emily Pimblett | SVP, Finance & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Mar 2025 | 5,000 | 16,329 | - | - | Common Stock | |
| Climb Bio Inc. | Emily Pimblett | SVP, Finance & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Mar 2025 | 5,000 | 20,000 | - | - | Restricted Stock Units | |
| Climb Bio Inc. | Emily Pimblett | SVP, Finance & CAO | Sale of securities on an exchange or to another person at price $ 1.31 per share. | 18 Mar 2025 | 1,199 | 15,130 | - | 1.3 | 1,571 | Common Stock |
| Climb Bio Inc. | Emily Pimblett | SVP, Finance and CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2025 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Climb Bio Inc. | Pimblett Emily | CHIEF ACCOUNTING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Dec 2024 | 5,000 | 25,000 | - | - | Restricted Stock Units | |
| Climb Bio Inc. | Pimblett Emily | CHIEF ACCOUNTING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Dec 2024 | 5,000 | 12,564 | - | - | Common Stock | |
| Climb Bio Inc. | Emily Pimblett | CHIEF ACCOUNTING OFFICER | Sale of securities on an exchange or to another person at price $ 2.02 per share. | 18 Dec 2024 | 1,235 | 11,329 | - | 2.0 | 2,495 | Common Stock |
| Climb Bio Inc. | Emily Pimblett | CHIEF ACCOUNTING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Sep 2024 | 5,000 | 30,000 | - | - | Restricted Stock Units | |
| Climb Bio Inc. | Emily Pimblett | CHIEF ACCOUNTING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Sep 2024 | 5,000 | 8,755 | - | - | Common Stock | |
| Climb Bio Inc. | Emily Pimblett | CHIEF ACCOUNTING OFFICER | Sale of securities on an exchange or to another person at price $ 8.18 per share. | 18 Sep 2024 | 1,182 | 7,573 | - | 8.2 | 9,669 | Common Stock |
| Climb Bio Inc. | Emily Pimblett | CHIEF ACCOUNTING OFFICER | Sale of securities on an exchange or to another person at price $ 8.11 per share. | 18 Sep 2024 | 9 | 7,564 | - | 8.1 | 73 | Common Stock |
| Climb Bio Inc. | Emily Pimblett | CHIEF ACCOUNTING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jun 2024 | 5,000 | 5,000 | - | - | Common Stock | |
| Climb Bio Inc. | Emily Pimblett | CHIEF ACCOUNTING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jun 2024 | 5,000 | 35,000 | - | - | Restricted Stock Units | |
| Climb Bio Inc. | Emily Pimblett | CHIEF ACCOUNTING OFFICER | Sale of securities on an exchange or to another person at price $ 7.21 per share. | 18 Jun 2024 | 1,245 | 3,755 | - | 7.2 | 8,982 | Common Stock |
| Climb Bio Inc. | Emily Pimblett | CHIEF ACCOUNTING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Mar 2024 | 40,000 | 40,000 | - | - | Restricted Stock Units |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges